Researchers have identified new variations in neuroblastoma that could lead to a more accurate prognosis and better-targeted treatments...

One of the research focal points of Dr. Josep Samitier's group (Nanobioengineering Group of IBEC), led by Dr. Aránzazu Villasante, is the...

A switch between cell states within MYCN-amplified neuroblastoma promotes KDM4, inhibition of which shows promising anticancer potential....

Families of paediatric cancer patients have helped move a pioneering treatment for neuroblastoma from the lab to the clinic. Could this...

Using data from a randomized phase III clinical trial of neuroblastoma patients (treated with or without immunotherapy) performed by the...

Roberto Chiarle, MD, at Boston Children's Hospital and his colleagues now report a way to make CAR-T cell therapy work better in...

Researchers have newly identified a universal, essential biomarker for the childhood cancer neuroblastoma – and a potential new target...

New NCCN Guidelines for Neuroblastoma address the importance and impact of risk stratification for treating one of the more common types...

A UCF cancer researcher is discovering ways that the body's own natural killer (NK) cells can be energized to fight deadly pediatric...

Liquid biopsies are a promise for the future of personalized cancer medicine: Many children with high-risk neuroblastoma, i.e. 50 percent...